Vivanza Biosciences Ltd is in the business of Pharmaceutical ProductsBusiness Overview: Vivanza Biosciences Limited is a specialty pharma company focused on commercializing novel and generic pharmaceuticals, developing oral drug delivery systems, and having expertise in complex oral and topical dose forms including highly potent compounds, modified release products & injections
Outcome of the 44th Annual General Meeting of the Members of the Vivanza Biosciences Limited.
Vivanza Biosciences has announced its 44th Annual General Meeting (AGM) will be held on Friday, September 11, 2026, at 3:30 P.M. via video conference. The company has dispatched the Annual Report for FY 2025-26 to shareholders. Remote e-voting will be available from September 8, 2026, 9:00 a.m. to September 10,...
Annual Report for the Financial Year 2025-2026 of the Company.
Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26
Vivanza Bio Board met: Approved FY25-26 reports and the 44th AGM. Shareholders will consider new MoA/AoA, higher borrowing limits, and significant related party transactions/financial dealings. #VivanzaBio
